英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
astromancy查看 astromancy 在百度字典中的解释百度英翻中〔查看〕
astromancy查看 astromancy 在Google字典中的解释Google英翻中〔查看〕
astromancy查看 astromancy 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) extended . . .
    AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and for the treatment of tardive dyskinesia
  • AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
    Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements See safety info including Boxed Warning
  • AUS-47312 XR HD:TD AUSTEDO Prescribing Information Digitial v6
    2 1 Dosing Information The dose of AUSTEDO XR and AUSTEDO is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability Table 1 displays the recommended dosage and important administration instructions of AUSTEDO XR and AUSTEDO when first prescribed to patients who are not being switched from tetrabenazine (a related VMAT2 inhibitor)
  • AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR . . . - BioSpace
    The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led to reductions in the severity of involuntary movements and improvements in patient-reported quality of life
  • Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
    Austedo's drug class is a VMAT2 inhibitor (vesicular monoamine transporter 2 inhibitor) Austedo tablets are taken twice daily, and the Austedo XR (extended-release) tablets are taken once daily What is Tardive dyskinesia (TD) and chorea associated with Huntington’s disease
  • AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® - GlobeNewswire
    The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia (TD) led to reductions in the
  • Teva Pharmaceutical Industries Ltd. - Teva Announces AUSTEDO® XR . . .
    U S FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg day) AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 (VMAT2) inhibitor for effective and tolerable tardive dyskinesia (TD) and Huntington’s disease (HD) chorea control1 Patients with TD taking AUSTEDO XR can expect symptom improvement as early as two
  • Teva Pharmaceuticals Reports Positive Real-World Data on AUSTEDO and . . .
    Teva Pharmaceuticals presented new findings from the IMPACT-TD Registry indicating that treatment with AUSTEDO and AUSTEDO XR significantly improved the lives of adults with tardive dyskinesia (TD) In a cohort of 27 participants, up to 77% reported enhancements in daily activities such as speech and eating after three months of treatment
  • AUSTEDO® XR: Tardive Dyskinesia and Huntingtons Chorea Treatment
    AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea See safety info including Boxed Warning
  • Austedo (deutetrabenazine): Uses, Side Effects, and More
    Learn about uses, side effects, and more for Austedo (deutetrabenazine), a drug that treats tardive dyskinesia and chorea related to Huntington’s disease





中文字典-英文字典  2005-2009